Washington, DC - In a study making the case for a new embolic-protection device, a trial of more than 700 patients with saphenous vein graft (SVG) disease has shown that the new SpideRX ...
Please provide your email address to receive an email when new articles are posted on . The use of embolic protection devices increased in interventional procedures, but the devices did not provide ...
Use of embolic protection devices during saphenous vein graft (SVG) interventions is associated with an increase in procedural complications without corresponding improvements in clinical outcomes for ...
United States Embolic Protection Device Market is expected to reach US$ 650 million by 2033 from US$ 360 million in 2024, with a CAGR of 6.96% from 2025 to 2033. Rising cardiovascular operations, ...
DUBLIN, Oct. 9, 2020 /PRNewswire/ -- The "Embolic Protection Devices Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The market is growing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback